Follow The Filings

PHIO Phio Pharmaceuticals

Phio Pharmaceuticals earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by PHIO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PHIO insider trades
  • $91K bought by 3 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Ronald Todd Plott Director
    Buy
    $10K 10,000 shares at $1.04 +31% to stake
    Traded Sep 28–29 Filed Sep 30
    ↗
  2. Patricia A Bradford Director
    Buy
    $6,583 6,500 shares at $1.01 +11% to stake
    Traded Sep 24 Filed Sep 25
    ↗
  3. Robert J Bitterman CEO
    Buy
    $2,058 2,000 shares at $1.03 +0.6% to stake
    Traded Sep 22 Filed Sep 23
    ↗
  4. Patricia A Bradford Director
    Buy
    $12K 12,000 shares at $1.03 +26% to stake
    Traded Sep 15 Filed Sep 16
    ↗
  5. Ronald Todd Plott Director
    Buy
    $17K 15,000 shares at $1.14 New stake
    Traded Aug 19 Filed Aug 20
    ↗
  6. Robert J Bitterman CEO
    Buy
    $11K 10,000 shares at $1.06 +2.4% to stake
    Traded Aug 18 Filed Aug 19
    ↗
  7. Robert J Bitterman CEO
    Buy
    $9,900 10,000 shares at $0.9900 +2.4% to stake
    Traded Jun 26 Filed Jun 29
    ↗
  8. Robert J Bitterman CEO
    Buy
    $5,150 5,000 shares at $1.03 +1.7% to stake
    Traded Dec 31, 2025 Filed Jan 2
    ↗
  9. Robert J Bitterman CEO
    Buy
    $5,100 5,000 shares at $1.02 +1.8% to stake
    Traded Dec 23, 2025 Filed Dec 29, 2025
    ↗
  10. Robert J Bitterman CEO
    Buy
    $5,700 5,000 shares at $1.14 +1.8% to stake
    Traded Nov 21, 2025 Filed Nov 24, 2025
    ↗
  11. Robert J Bitterman CEO
    Buy
    $6,350 5,000 shares at $1.27 +1.8% to stake
    Traded Nov 18, 2025 Filed Nov 19, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 9 stock grants and 2 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
8-K 8.01,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
DEF 14A FORM DEF 14A Filing Doc
DEFA14A ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
424B5 PROSPECTUS SUPPLEMENT Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K FORM 10-K Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.